Evidence map›Paper›PMID 34395239›Full record

ArticleFrontiers in oncology2021

A Novel Mechanism of the c-Myc/NEAT1 Axis Mediating Colorectal Cancer Cell Response to Photodynamic Therapy Treatment.

Kuijie Liu, Sanlin Lei, Yong Kuang, Qianqian Jin, Dongju Long, Chao Liu, Yuhong Jiang, Hua Zhao, Hongliang Yao

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Significant position of C-myc in colorectal cancer: a promising therapeutic target.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2022
    Review
  11. Review
  12. Review
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Kuijie LiuDepartment of Gastroenterology, The Second Xiangya Hospital, Central South University, Changsha, China.
Sanlin LeiDepartment of Gastroenterology, The Second Xiangya Hospital, Central South University, Changsha, China.
Yong KuangDepartment of Gastroenterology, The Second Xiangya Hospital, Central South University, Changsha, China.
Qianqian JinDepartment of Gastroenterology, The Second Xiangya Hospital, Central South University, Changsha, China.
Dongju LongDepartment of Gastroenterology, The Second Xiangya Hospital, Central South University, Changsha, China.
Chao LiuDepartment of Gastroenterology, The Second Xiangya Hospital, Central South University, Changsha, China.
Yuhong JiangDepartment of Gastroenterology, The Second Xiangya Hospital, Central South University, Changsha, China.
Hua ZhaoDepartment of Gastroenterology, The Second Xiangya Hospital, Central South University, Changsha, China.
Hongliang YaoDepartment of Gastroenterology, The Second Xiangya Hospital, Central South University, Changsha, China.
Second Xiangya Hospital of Central South University · CNCentral South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Photodynamic therapy (PDT) is considered a potential treatment regimen for colorectal cancer cases (CRC). p53 signaling and the miR-124/iASPP axis play an essential role in the PDT resistance of CRC cells. PDT treatment downregulated NEAT1 expression in p53

Indexed as

c-Myccolorectal cancerNEAT1photodynamic therapy (PDT)the miR-124/iASPP/p53 feedback loop

Identifiers

PMID34395239
PMCPMC8355738
OpenAlexW3185263441

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.